FindTrial
Sign In

Evaluation of Diagnostic Markers of Hepatic Bile Pancreatic and Gastrointestinal Tumors and Multivariate Comprehensive Study

Evaluation of Diagnostic Markers of Hepatic Bile Pancreatic and Gastrointestinal Tumors and Multivariate Comprehensive Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RRC-17012842
Enrollment
Unknown
Registered
2017-09-29
Start date
2017-10-01
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatobiliary and pancreatic and gastrointestinal tumors

Interventions

Tumor group:surgery
Others:surgery

Sponsors

the Second Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 90 Years

Inclusion criteria

Inclusion criteria: Imaging or serology and clinical diagnosis may be suspected of patients

Exclusion criteria

Exclusion criteria: After diagnosis with the pathology, the exclusion of pre-diagnosis of patients with errors

Design outcomes

Primary

MeasureTime frame
male and female;AFP;HBsAg;CA199;CA125;CEA;Alkaline phosphatase;Cirrhosis;diameter;number;embolus;capsulation;lymphod involvement;differentiation;OS-2Y;osstate-2y;os-5y;osstate-5y;OS;os-state;DFS-2Y;DFSSTATE-2Y;DFS-5Y;DFSSTATE-5Y;—

Secondary

MeasureTime frame
age;child;Alanine aminotransferase;Total bilirubin;ALT;GGT;—

Countries

China

Contacts

Public ContactBi-mang Fu
fubimang@163.com+86 13888192666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026